Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud

BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud

Jan 11, 2021
|
staff reporter

This article has been updated with a comment from BGI's subsidiary Complete Genomics.

NEW YORK – BGI and its subsidiaries MGI and Complete Genomics have sued Illumina for violation of federal antitrust and California unfair competition laws, claiming that Illumina used "fraudulent behavior" to obtain or enforce three sequencing patents that it has asserted against BGI, preventing that firm from entering the US market with its CoolMPS sequencing technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Worries About Increased Deadliness

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Merck Stops SARS-CoV-2 Vaccine Development

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

Jan
28
Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Sponsored by
Sophia Genetics

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources. 

Feb
11
Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Sponsored by
Foundation Medicine

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb
17
Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Sponsored by
BioLegend

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Feb
18
Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

Sponsored by
BD

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression. 

What's Popular?

In Sequencing

  1. Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics

    Premium

  2. Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates

  3. Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease

    Premium

  4. Microba, University of Queensland Partner to Study Gut Microbiome in Parkinson's Disease

  5. Sano Genetics Raises £2.5M in Private Seed Funding

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.